Essex Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
RW
Essex Financial Services's IHE Position: Q3 2024 in Review
Essex Financial Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2024, closing a stake of 4,101 shares — an estimated $280K sold.
Essex Financial Services first reported a position in IHE in Q4 2013 and held it in 24 quarters. The position peaked at $280K in Q2 2024. 143 funds tracked by Wall St. Rank hold IHE as of Q3 2024.
- Essex Financial Services reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2024 after selling out during the quarter.
- Essex Financial Services sold 4,101 iShares US Pharmaceuticals ETF shares in Q3 2024, an estimated $280K.
- Essex Financial Services first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 24 quarters.
- Essex Financial Services's iShares US Pharmaceuticals ETF position peaked at $280K in Q2 2024.
- 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2024.
Based on Essex Financial Services's 13F filing for Q3 2024, filed 24 Oct 2024.